We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Coagulants.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

Coagulants×マーケットリサーチセンター - List of Manufacturers, Suppliers, Companies and Products

Coagulants Product List

1~2 item / All 2 items

Displayed results

[Research Material] The Global Market for Anticoagulant Therapy

Global Market for Anticoagulant Therapy: NOACs, Warfarin, In-Hospital Clinics, Independent Clinics, Pharmacy-Based Clinics

This research report (Global Anticoagulation Therapy Market) investigates and analyzes the current state of the global anticoagulation therapy market and its outlook for the next five years. It includes information on the overview of the global anticoagulation therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anticoagulation therapy market focus on NOAC and warfarin, while the segments by application target inpatient clinics, independent clinics, and pharmacy-based clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of anticoagulation therapy. It also includes the market share of major companies in anticoagulation therapy, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Global Market for Stroke Prevention in Atrial Fibrillation (SPAF) Treatment

Global Market for Stroke Prevention in Atrial Fibrillation (SPAF) Treatment: Oral Direct Thrombin Inhibitors, Oral Direct Factor Xa Inhibitors, Hospitals, Clinics ...

This research report (Global Stroke Prevention in Atrial Fibrillation (SPAF)) investigates and analyzes the current state and future outlook of the global market for stroke prevention in the treatment of atrial fibrillation (SPAF) over the next five years. It includes information on the overview of the global stroke prevention market in atrial fibrillation (SPAF) treatment, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for stroke prevention in atrial fibrillation (SPAF) treatment by type focus on oral direct thrombin inhibitors and oral direct factor Xa inhibitors, while the segments by application target hospitals, clinics, and outpatient surgical centers. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for stroke prevention in atrial fibrillation (SPAF) treatment. It also includes the market share of major companies in stroke prevention for atrial fibrillation (SPAF) treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration